Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study

<b>Background:</b> Exacerbation of chronic obstructive pulmonary disease (ECOPD) significantly impact health status, hospitalization rates, and disease progression, and are linked to increased mortality. Predictive factors for ECOPD are therefore of considerable interest. The limited understanding of interleukin 16 (IL-16) and IL-25 role in ECOPD provided the rationale for this study. <b>Methods</b>: Fifty ex-smokers diagnosed with COPD (22 ECOPD and 28 patients in the stable phase of the disease) underwent prospective analysis to evaluate the role of I IL-25 as predictive markers of clinical outcomes in ECOPD. <b>Results:</b> We observed a significantly lower IL-16 and higher IL-25 concentrations among ECOPD patients (<i>p</i> = 0.002 and <i>p</i> = 0.01 respectively). We also detected a significant negative correlation between IL-16 and neutrophil-to-lymphocyte ratio (NLR) (<i>p</i> = 0.04) and a significant negative correlation between IL-25 concentration and absolute eosinophil count (<i>p</i> = 0.04). In the entire group, we observed a positive correlation between IL-16 and both FEV1 and FVC, both expressed as a percentage of reference value, (<i>p</i> = 0.002 and <i>p</i> = 0.0004 respectively). However, after stratification to ECOPD and stable COPD group, significance maintained for FVC (<i>p</i> = 0.045 for ECOPD and <i>p</i> = 0.02 for stable COPD). In survival analysis, we detected significantly lower all-cause mortality for 3rd tertile of IL-16 concentrations, with a hazard ratio of 0.33 (95%CI: 0.11-0.98; <i>p</i> = 0.04). <b>Conclusions</b>: Lower IL-16 levels among ECOPD patients may indicate a feedback mechanism linked to heightened Th1 response activation. Observed correlations with ventilatory parameters and survival also seems to reflect this mechanism. The higher IL-25 concentrations observed in ECOPD patients, along with the negative correlation with absolute eosinophil count and eosinopenia, suggest multifactorial regulation and independent functions of eosinophils and IL-25. Hypothetically, this paradox may be related to the Th1/Th2 imbalance favoring Th1 response. Obtained results should be reproduced in larger size samples.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2024-09-01
DOI
https://doi.org/10.3390/jcm13175188
Citations
1
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study

Adam Białas, Tomasz Karauda, Anna Kumor‐Kisielewska, Joanna Miłkowska-Dymanowska et al.
1 citations
Journal of Clinical Medicine
Chronic Obstructive Pulmonary Disease (COPD) Research
0.42
article

Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study

Adam Białas, Tomasz Karauda, Anna Kumor‐Kisielewska, Joanna Miłkowska-Dymanowska, Wojciech Piotrowski
article en
1 citations

Abstract

<b>Background:</b> Exacerbation of chronic obstructive pulmonary disease (ECOPD) significantly impact health status, hospitalization rates, and disease progression, and are linked to increased mortality. Predictive factors for ECOPD are therefore of considerable interest. The limited understanding of interleukin 16 (IL-16) and IL-25 role in ECOPD provided the rationale for this study. <b>Methods</b>: Fifty ex-smokers diagnosed with COPD (22 ECOPD and 28 patients in the stable phase of the disease) underwent prospective analysis to evaluate the role of I IL-25 as predictive markers of clinical outcomes in ECOPD. <b>Results:</b> We observed a significantly lower IL-16 and higher IL-25 concentrations among ECOPD patients (<i>p</i> = 0.002 and <i>p</i> = 0.01 respectively). We also detected a significant negative correlation between IL-16 and neutrophil-to-lymphocyte ratio (NLR) (<i>p</i> = 0.04) and a significant negative correlation between IL-25 concentration and absolute eosinophil count (<i>p</i> = 0.04). In the entire group, we observed a positive correlation between IL-16 and both FEV1 and FVC, both expressed as a percentage of reference value, (<i>p</i> = 0.002 and <i>p</i> = 0.0004 respectively). However, after stratification to ECOPD and stable COPD group, significance maintained for FVC (<i>p</i> = 0.045 for ECOPD and <i>p</i> = 0.02 for stable COPD). In survival analysis, we detected significantly lower all-cause mortality for 3rd tertile of IL-16 concentrations, with a hazard ratio of 0.33 (95%CI: 0.11-0.98; <i>p</i> = 0.04). <b>Conclusions</b>: Lower IL-16 levels among ECOPD patients may indicate a feedback mechanism linked to heightened Th1 response activation. Observed correlations with ventilatory parameters and survival also seems to reflect this mechanism. The higher IL-25 concentrations observed in ECOPD patients, along with the negative correlation with absolute eosinophil count and eosinopenia, suggest multifactorial regulation and independent functions of eosinophils and IL-25. Hypothetically, this paradox may be related to the Th1/Th2 imbalance favoring Th1 response. Obtained results should be reproduced in larger size samples.

Journal of Clinical MedicineVol. 13(17)
Medical University of Lodz (PL)
Uniwersytet Łódzki
Good health and well-being
Openalex Percentile: Top 33%
Chronic Obstructive Pulmonary Disease (COPD) Research
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.